If Waylivra (Volanesorsen) Isn't Approved by Cigna in Ohio: Formulary Alternatives and Exception Strategies
Answer Box: Your Path Forward in Ohio
Waylivra (volanesorsen) is not FDA-approved in the United States, making coverage extremely difficult. However, Ohio patients with familial chylomicronemia syndrome (FCS) have better options: Tryngolza (olezarsen) received FDA approval in 2024 and is covered by Cigna with proper documentation. If you need Waylivra